Charles Schwab Investment Management Inc Amphastar Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 359,222 shares of AMPH stock, worth $17.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
359,222
Previous 356,405
0.79%
Holding current value
$17.2 Million
Previous $15.6 Million
8.19%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$285 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$128 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$93.4 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$81.2 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$77.9 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.35B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...